Corcept Therapeutics’ selective cortisol modulator failed to slow the progress of amyotrophic lateral sclerosis (ALS) in a ...
Over a decade into selling Korlym to treat endogenous hypercortisolism, also known as Cushing syndrome, Corcept Therapeutics ...
US FDA approves Neurocrine Biosciences’ Crenessity to treat children and adults with classic congenital adrenal hyperplasia: San Diego Monday, December 16, 2024, 16:00 Hrs [IST] ...
The U.S. Food and Drug Administration has approved Neurocrine Biosciences' drug to treat a type of genetic disorder, the ...
The FDA has approved Neurocrine Bioscience's Crenessity for classic congenital adrenal hyperplasia (CAH), the first drug for ...
Neurocrine Biosciences stock jumped Monday after the company won FDA approval for the first new treatment for an adrenal disease in decade ...
We all have unique schedules, challenges, and responsibilities. But there’s one thing almost everyone can relate to while ...
Hosted on MSN4d
Woman finds massive 11 lb mushroomWoman finds massive 11 lb mushroom ...
Research from Washington University shows that glioblastoma, a type of brain cancer, has its own internal clock that ...
New research shows that glioblastoma has an internal clock and syncs its daily rhythms to match -- and take advantage of -- the rhythms of its host. In this way, brain tumors grow in response to the ...
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe e ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback